Kawagoe, Japan

Kunio Nakagawa

This inventor holds 6 USPTO granted patents. Top assignee: Nisshin Flour Milling Co., Ltd.. Active years: 1976-1978.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kunio Nakagawa. Retrieved from https://idiyas.com/inventor/kunio-nakagawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 1976-1978

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Kunio Nakagawa: Innovator in Antiphlogistic Compounds

Introduction

Kunio Nakagawa is a prominent inventor based in Kawagoe, Japan. He has made significant contributions to the field of chemistry, particularly in the development of compounds with antiphlogistic activity. With a total of six patents to his name, Nakagawa's work has implications for the pharmaceutical industry.

Latest Patents

Among his latest patents, Nakagawa has developed butenoic and pyruvic acid derivatives, specifically 2-hydroxy-butenoic acid derivatives. These compounds are noted for their antiphlogistic properties. Additionally, he has created a process for preparing 3-methyl-3-(substituted aryl)-pyruvic acid compounds. This process involves treating a glycidic acid ester compound with a Lewis acid, leading to the formation of useful anti-inflammatory agents.

Career Highlights

Nakagawa is associated with Nisshin Flour Milling Co., Ltd., where he continues to innovate in his field. His work has garnered attention for its potential applications in medicine and therapeutic treatments.

Collaborations

He has collaborated with notable coworkers, including Katsura Kogure and Noriyoshi Sueda, contributing to the advancement of their shared research goals.

Conclusion

Kunio Nakagawa's contributions to the field of chemistry, particularly in the development of antiphlogistic compounds, highlight his role as an influential inventor. His ongoing work promises to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…